Ontology highlight
ABSTRACT:
SUBMITTER: Ballestin A
PROVIDER: S-EPMC10937439 | biostudies-literature | 2024
REPOSITORIES: biostudies-literature

Frontiers in immunology 20240229
Glioblastoma is a highly aggressive and invasive tumor that affects the central nervous system (CNS). With a five-year survival rate of only 6.9% and a median survival time of eight months, it has the lowest survival rate among CNS tumors. Its treatment consists of surgical resection, subsequent fractionated radiotherapy and concomitant and adjuvant chemotherapy with temozolomide. Despite the implementation of clinical interventions, recurrence is a common occurrence, with over 80% of cases aris ...[more]